showed left renal atrophy, renal right and splenic infarction. After CT contrast, new laboratory tests showed serum creatinine: 5.5mg/dL and urea: 124mg/dL. Urinalysis revealed 1+ protein, 2+ white blood cells and 4+ red blood cells. The complementary investigation showed anti-cardiolipin antibodies (aCL) positive in high titers; antinuclear antibodies (ANA), myeloperoxidase-antineutrophil cytoplasmic antibody (c-ANCA) and anti-nuclear antibody (ANA) were negative. The serology for hepatitis A, B and C negative; ELISA anti-HIV and VDRL were also negative. The urinary protein excretion was 1.44g/24h and creatinine clearance was 39mL/min/1,73m 2 . A diagnosis of renal and splenic infarction due to antiphospholipid syndrome was made and the patient received treatment with subcutaneous heparin followed by warfarin.
Discussion:
The antiphospholipid syndrome (APS) was first described by Hughes in the 1980s as a disorder of hypercoagulability in association with antiphospholipid antibodies. 1 APS may occur, though less frequently, in the absence of associated autoimmune disease, the so-called primary APS. The diagnosis of APS is made when the patient fulfils at least one clinical (vascular thrombosis or pregnancy morbidity) and one laboratory [LA, aCL and/or anti-β2-gylycoprotein-1 (anti-â2GP1) antibodies] criterion. 2 Arterial thromboses are less common than venous thromboses and occur in a variety of settings in patients with primary APS. Patients with arterial thrombosis most commonly present with transient ischemic attack or stroke (50%) or myocardial infarction (23%). 3 The renal manifestations of APS thus may include renal artery stenosis (RAS) and/or renovascular hypertension, renal infarction, APS nephropathy (APSN), renal vein thrombosis, and increased allograft vascular thrombosis. 4 All vascular structures of the kidney may be affected, leading to diverse clinical consequences including severe hypertension, proteinuria, hematuria, nephrotic syndrome, and renal failure. In some instances end stage renal disease (ESRD) may occur. 5 
